Abstract:BACKGROUND:One of the major goals in gene and protein expression profiling of cancer is to identify biomarkers and build classification models for prediction of disease prognosis or treatment response. Many traditional statistical methods, based on microarray gene expression data alone and individual genes' discriminatory power, often fail to identify biologically meaningful biomarkers thus resulting in poor prediction performance across data sets. Nonetheless, the variables in multivariable classifiers should synergistically interact to produce more effective classifiers than individual biomarkers.RESULTS:We developed an integrated approach, namely network-constrained support vector machine (netSVM), for cancer biomarker identification with an improved prediction performance. The netSVM approach is specifically designed for network biomarker identification by integrating gene expression data and protein-protein interaction data. We first evaluated the effectiveness of netSVM using simulation studies, demonstrating its improved performance over state-of-the-art network-based methods and gene-based methods for network biomarker identification. We then applied the netSVM approach to two breast cancer data sets to identify prognostic signatures for prediction of breast cancer metastasis. The experimental results show that: (1) network biomarkers identified by netSVM are highly enriched in biological pathways associated with cancer progression; (2) prediction performance is much improved when tested across different data sets. Specifically, many genes related to apoptosis, cell cycle, and cell proliferation, which are hallmark signatures of breast cancer metastasis, were identified by the netSVM approach. More importantly, several novel hub genes, biologically important with many interactions in PPI network but often showing little change in expression as compared with their downstream genes, were also identified as network biomarkers; the genes were enriched in signaling pathways such as TGF-beta signaling pathway, MAPK signaling pathway, and JAK-STAT signaling pathway. These signaling pathways may provide new insight to the underlying mechanism of breast cancer metastasis.CONCLUSIONS:We have developed a network-based approach for cancer biomarker identification, netSVM, resulting in an improved prediction performance with network biomarkers. We have applied the netSVM approach to breast cancer gene expression data to predict metastasis in patients. Network biomarkers identified by netSVM reveal potential signaling pathways associated with breast cancer metastasis, and help improve the prediction performance across independent data sets.

Identifying Cancer Biomarkers by Network-Constrained Support Vector Machines.

Biomarker discovery from high-throughput data by connected network-constrained support vector machine

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

Identification of Prognostic and Heterogeneous Breast Cancer Biomarkers Based on Fusion Network and Multiple Scoring Strategies.

Network-Based Inference Framework for Identifying Cancer Genes from Gene Expression Data

Network-based Multi-Task Learning Models for Biomarker Selection and Cancer Outcome Prediction.

Network as a Biomarker: A Novel Network-Based Sparse Bayesian Machine for Pathway-Driven Drug Response Prediction

Identification of Breast Cancer Metastasis Markers from Gene Expression Profiles Using Machine Learning Approaches

Integrating Prior Knowledge Into Prognostic Biomarker Discovery based on Network Structure

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

Identifying network biomarkers based on protein-protein interactions and expression data

Network-based cancer genomic data integration for pattern discovery

Identifying the Gene Signatures from Gene-Pathway Bipartite Network Guarantees the Robust Model Performance on Predicting the Cancer Prognosis.

Cancer Subtype Discovery and Biomarker Identification Via a New Robust Network Clustering Algorithm.

Incorporating gene co-expression network in identification of cancer prognosis markers

Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients

Identification of Diagnostic Markers for Breast Cancer Based on Differential Gene Expression and Pathway Network

Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated With Prognosis

Network-based machine learning approach to predict immunotherapy response in cancer patients

Discovering Explainable Biomarkers for Breast Cancer Anti-PD1 Response via Network Shapley Value Analysis